There are no significant differences in outcomes post-AMI in patients with systemic lupus erythematosus vs the general population.

Immune cells called monocytes produce a key inflammatory protein called interleukin-1 beta (IL-1β) through an unconventional ...

Clinical stage biopharma Kezar Life Sciences is discontinuing its lupus nephritis (LN) clinical programme following the death ...

New research suggests that higher daily intakes of ultraprocessed foods (UPFs) are associated with a higher risk of ...

Systemic lupus can be mild or severe. Cutaneous lupus erythematosus This form of lupus is limited to the skin and can cause many types of rashes and lesions. Drug-induced lupus erythematosus This is a ...

A new study suggests that your morning cup of coffee might do more than just wake you up – it could be giving your blood ...

Cambridge, Massachusetts Thursday, October 17, 2024, 17:00 Hrs [IST] ...

Doctors in China said a homegrown cell therapy saw initial success in children with a severe autoimmune disorder, the latest ...

The following is a summary of “Coronary Artery Calcification Progression in Patients With Systemic Lupus Erythematosus,” ...

Exocrine pancreatic insufficiency (EPI) occurs in chronic pancreatitis, cystic fibrosis, autoimmune disorders such as Crohn’s disease and systemic lupus erythematosus and patients that have had parts ...

The Global Systemic Lupus Erythematosus Treatment Market is valued approximately at USD 2.95 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 8.64% over the forecast ...